QUAKER HOUGHTON ANNOUNCES THIRD QUARTER 2025 RESULTS

30.10.25 21:30 Uhr

Werte in diesem Artikel

  • Q3'25 net sales of $493.8 million, an increase of 7% Y/Y
  • Organic sales volumes increased 3% Y/Y driven by new business wins of approximately 5%
  • Q3'25 net income of $30.5 million and earnings per diluted share of $1.75
  • Non-GAAP net income of $36.3 million and non-GAAP earnings per diluted share of $2.08, an increase of 10% Y/Y
  • Delivered adjusted EBITDA of $82.9 million, a 5% increase Y/Y, and adjusted EBITDA margins of 16.8%
  • Generated $51.4 million of operating cash flow in Q3'25; Reduced net leverage ratio to 2.4x

CONSHOHOCKEN, Pa., Oct. 30, 2025 /PRNewswire/ -- Quaker Houghton ("the Company") (NYSE: KWR), the global leader in industrial process fluids, announced its third quarter 2025 results today.


Three Months Ended
September 30,

Nine Months Ended
September 30,

($ in thousands, except per share data)

2025

2024

2025

2024

Net sales

$            493,842

$            462,274

$      1,420,156

$      1,395,600

Net income (loss) attributable to Quaker Chemical Corporation

30,469

32,346

(23,189)

102,458

Net income (loss) attributable to Quaker Chemical Corporation common shareholders – diluted

 

1.75

 

1.81

 

(1.32)

 

5.70

Non-GAAP net income *

36,270

33,981

94,298

109,886

Non-GAAP Earnings per diluted share *

2.08

1.89

5.37

6.11

Adjusted EBITDA *

82,851

78,562

227,377

246,135



*

Refer to the Non-GAAP Measures and Reconciliations section below for additional information

Third Quarter 2025 Consolidated Results

Net sales in the third quarter of 2025 were $493.8 million, an increase of 7% compared to $462.3 million in the third quarter of 2024. This increase was primarily driven by an increase in organic sales volumes of 3%, a contribution from acquisitions of 5% and a favorable impact from foreign currency translation of 1%, partially offset by a decline in selling price and product mix of 2%. Organic sales volumes increased in all segments compared to the prior year, led by an 8% increase in the Asia/Pacific segment. This improvement in organic sales volumes was primarily driven by new business wins of approximately 5% globally, more than offsetting a continuation of soft end market conditions, particularly in the Americas and EMEA segments. The decrease in selling price and product mix was primarily attributable to the impact of the mix of products, services and geographies and the impact of our index-based customer contracts. Organic sales volumes increased 1% compared to the second quarter of 2025.

The Company reported net income in the third quarter of 2025 of $30.5 million, or $1.75 per diluted share, compared to $32.3 million, or $1.81 per diluted share, in the third quarter of 2024. Excluding non-recurring and non-core items in each period, the Company's non-GAAP net income and non-GAAP earnings per diluted share were $36.3 million and $2.08 respectively in the third quarter of  2025 compared to $34.0 million and $1.89 respectively in the third quarter of 2024. The Company generated adjusted EBITDA of $82.9 million in the third quarter of 2025, an increase of approximately 5% compared to $78.6 million in the third quarter of 2024, driven by the increase in net sales and consistent operating margins. See the Non-GAAP Measures and Reconciliations section below for additional information.

Joe Berquist, Chief Executive Officer and President, commented, "Third quarter results were strong, resulting from the team's disciplined execution of our strategy. We achieved a 7% increase in sales on 3% organic volume growth, and a 5% improvement in adjusted EBITDA in the quarter, despite a softer than anticipated end market environment. Our performance was driven by new business wins of approximately 5% globally and amplified by continued momentum in Asia/Pacific. We are advancing our strategic initiatives, leveraging our scale and managing costs to enhance our global competitiveness and improve margins. Solid cash generation enabled us to further strengthen our balance sheet and return cash to shareholders through dividends and share repurchases.

"We anticipate the current soft environment will persist at least through year end, with normal seasonality expected. The resilience of our business is evident. We are confident in our ability to convert our sales pipeline and have line of sight to execute our ongoing cost and productivity initiatives. We expect to deliver year-over-year revenue and earnings growth in the fourth quarter, and are building momentum on our enterprise strategy to sustain above market growth in 2026 and beyond."

Third Quarter 2025 Segment Results

The Company's third quarter and nine months of 2025 operating performance for each of its three reportable segments: (i) Americas; (ii) EMEA; and (iii) Asia/Pacific, is further described below.


Three Months Ended
September 30,

Nine Months Ended
September 30,


2025

2024

2025

2024

Net Sales *





Americas

$          222,787

$          220,275

$          657,560

$          673,546

EMEA

143,900

134,135

413,101

410,558

Asia/Pacific

127,155

107,864

349,495

311,496

Total net sales

$          493,842

$          462,274

$      1,420,156

$      1,395,600

Segment operating earnings *





Americas

$            58,913

$            62,121

$          176,351

$          193,027

EMEA

26,479

24,644

74,867

80,867

Asia/Pacific

35,569

30,656

90,214

92,033

Total segment operating earnings

$          120,961

$          117,421

$          341,432

$          365,927



*

Refer to the Segment Measures and Reconciliations section below for additional information

The following table summarizes the sales variances by reportable segment and consolidated operations in the third quarter of 2025 compared to the third quarter of 2024:


Sales 
volumes

Selling price &

product mix

Foreign
currency

Acquisition &

other

Total

Americas

— %

(2) %

1 %

2 %

1 %

EMEA

1 %

1 %

3 %

2 %

7 %

Asia/Pacific

8 %

(5) %

1 %

14 %

18 %

Consolidated

3 %

(2) %

1 %

5 %

7 %

Net sales in the Asia/Pacific segment increased 18% in the third quarter of 2025 compared to the same period in 2024, as an increase in organic sales volumes, a further contribution in sales from acquisitions, primarily Dipsol, and a favorable impact of foreign currency translation, was partially offset by a decrease in selling price and product and geographic mix. Net sales in the EMEA segment increased 7% in the third quarter of 2025 compared to the same period in 2024, due to an increase in organic sales volumes, a further increase in sales from acquisitions, an increase in selling price and product mix, and a favorable impact of foreign currency translation. Net sales in the Americas segment increased 1% in the third quarter of 2025 compared to the same period in 2024, due to a contribution in sales from acquisitions and a favorable impact from foreign currency translation, partially offset by a decline in selling price and product mix. Organic sales volumes in the Americas were consistent with the prior year period.

New business wins were strong across all segments in the third quarter of 2025 despite softer underlying end market activity compared to prior year levels. The decline in selling price and product mix in the third quarter of 2025 compared to the same period in 2024 reflects changes in the mix of products, services and geographies, and the impact of our index-based customer contracts.

Consolidated net sales increased approximately 2% compared to the second quarter of 2025, driven by an increase in organic sales volumes and a favorable impact from foreign currency translation. Selling price and product mix was consistent with the prior quarter. Net sales increased in all segments compared to the second quarter of 2025 driven by new business wins, despite a continuation of soft underlying end market activity. Organic sales volumes increased in the Asia/Pacific and Americas segments but declined in EMEA. Foreign currency translation was favorable to sales across all segments in the third quarter of 2025 compared to the second quarter of 2025.

Segment operating earnings increased in the EMEA and Asia/Pacific segments in the third quarter of 2025 compared to the prior year, primarily due to the improvement in net sales. Segment operating earnings decreased in the Americas segment in the third quarter of 2025 compared to the prior year as an increase in net sales was offset by a modest decline in segment operating margins. Segment operating earnings increased in the Asia/Pacific and EMEA segments in the third quarter of 2025 compared to the second quarter of 2025, primarily driven by an increase in net sales, and declined slightly in the Americas segment.

Cash Flow and Liquidity Highlights

Net cash provided by operating activities was $89.9 million for the nine months ended September 30, 2025, compared to $141.5 million for the same period in 2024. The Company's operating cash flow primarily reflects a lower operating performance, higher cash outflows from restructuring activities, and higher cash outflows for working capital activities, primarily due to lower inflows from the timing of collection of accounts receivable and higher outflows for the purchases of inventories.

As of September 30, 2025, the Company's total gross debt was $875.2 million and its cash and cash equivalents was $172.0 million, which resulted in net debt of approximately $703.2 million. The Company's net debt divided by its trailing twelve months adjusted EBITDA was approximately 2.4x. The increase in the company's leverage ratio compared to the prior year primarily reflects the Company's acquisition of Dipsol, which was completed in April 2025, and was funded with borrowings under the Company's existing credit facility. In the third quarter of 2025, the Company reduced outstanding gross debt by approximately $61.5 million compared to the second quarter of 2025, and repurchased 29,791 shares for $3.8 million.

Non-GAAP Measures and Reconciliations

The information in this press release includes non-GAAP (unaudited) financial information that includes EBITDA, adjusted EBITDA, adjusted EBITDA margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP gross profit, non-GAAP gross margin, taxes on income before equity in net income of associated companies – adjusted, non-GAAP net income and non-GAAP earnings per diluted share. The Company believes these non-GAAP financial measures provide meaningful supplemental information as they enhance a reader's understanding of the financial performance of the Company, facilitate a comparison among fiscal periods, and exclude items that management believes are not indicative of future operating performance or considered core to the Company's operations. Non-GAAP results are presented for supplemental informational purposes only and should not be considered a substitute for the financial information presented in accordance with GAAP. In addition, our definitions of EBITDA, adjusted EBITDA, adjusted EBITDA margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP gross profit, non-GAAP gross margin, taxes on income before equity in net income of associated companies – adjusted, non-GAAP net income, and non-GAAP earnings per diluted share, as discussed and reconciled below to the most comparable GAAP measures, may not be comparable to similarly named measures reported by other companies.

The Company presents EBITDA, which is calculated as net income attributable to the Company before depreciation and amortization, interest expense, and taxes on income before equity in net income of associated companies. The Company also presents adjusted EBITDA, which is calculated as EBITDA plus or minus certain items that management believes are not indicative of future operating performance or considered core to the Company's operations. In addition, the Company presents non-GAAP operating income, which is calculated as operating income plus or minus certain items that management believes are not indicative of future operating performance or considered core to the Company's operations. Additionally, the Company presents non-GAAP gross profit, which is calculated as gross profit plus or minus certain items that management believes are not indicative of future operating performance or considered core to the Company's operations. In addition, the Company presents non-GAAP Adjusted EBITDA margin, non-GAAP operating margin, and non-GAAP gross margin, which are calculated as the percentage of adjusted EBITDA, non-GAAP operating income, and non-GAAP gross profit to consolidated net sales, respectively. The Company believes these non-GAAP measures provide transparent and useful information and are widely used by analysts, investors, and competitors in our industry as well as by management in assessing the operating performance of the Company on a consistent basis.

Additionally, the Company presents non-GAAP net income and non-GAAP earnings per diluted share as additional performance measures. Non-GAAP net income is calculated as adjusted EBITDA, defined above, less depreciation and amortization, interest expense, and taxes on income before equity in net income of associated companies, in each case adjusted, as applicable, for any depreciation, amortization, interest or tax impacts resulting from the non-core items identified in the reconciliation of net income attributable to the Company to adjusted EBITDA. Non-GAAP earnings per diluted share is calculated as non-GAAP net income per diluted share as accounted for under the "two-class share method." The Company believes that non-GAAP net income and non-GAAP earnings per diluted share provide transparent and useful information and are widely used by analysts, investors, and competitors in our industry as well as by management in assessing the performance of the Company on a consistent basis.

As it relates to future projections for the Company as well as other forward-looking information contained in this press release, the Company has not provided guidance for comparable GAAP measures or a quantitative reconciliation of forward-looking non-GAAP financial measures to the most directly comparable U.S. GAAP measure because it is unable to determine with reasonable certainty the ultimate outcome of certain significant items necessary to calculate such measures without unreasonable effort. These items include, but are not limited to, certain non-recurring or non-core items the Company may record that could materially impact net income. These items are uncertain, depend on various factors, and could have a material impact on the U.S. GAAP reported results for the guidance period.

The Company's reference to trailing twelve months adjusted EBITDA within this press release refers to the twelve month period ended September 30, 2025 adjusted EBITDA of $292.2 million, which consists of (i) the nine months ended September 30, 2025 adjusted EBITDA of $227.4 million, as presented in the non-GAAP reconciliations below, and (ii) the twelve months ended December 31, 2024 adjusted EBITDA of $310.9 million, as presented in the non-GAAP reconciliations included in the Company's fourth quarter and full year 2024 results press release dated February 24, 2025, less (iii) the nine months ended September 30, 2024 adjusted EBITDA of $246.1 million, as presented in the non-GAAP reconciliations below.

Certain of the prior period non-GAAP financial measures presented in the following tables have been adjusted to conform with current period presentation. The following tables reconcile the Company's non-GAAP financial measures (unaudited) to their most directly comparable GAAP (unaudited) financial measures (dollars in thousands unless otherwise noted, except per share amounts):

Non-GAAP Gross Profit and Margin Reconciliations

Three Months Ended
September 30,

Nine Months Ended
September 30,


2025

2024

2025

2024

Gross profit

$      180,865

$      172,549

$      513,848

$      529,830

Acquisition-related step-up inventory amortization

6,022

Loss (gain) on inventory and other adjustments

671

(2,933)

Non-GAAP gross profit

$      181,536

$      172,549

$      516,937

$      529,830

Non-GAAP profit margin (%)

36.8 %

37.3 %

36.4 %

38.0 %

Non-GAAP Operating Income and Margin Reconciliations

Three Months Ended 
September 30,

Nine Months Ended 
September 30,


2025

2024

2025

2024

Operating income

$        46,641

$        51,718

$         21,755

$       165,693

Acquisition-related step-up inventory amortization

6,022

Restructuring and related charges, net

7,745

2,610

31,128

4,787

Acquisition-related expenses

642

381

4,775

898

Loss (gain) on inventory and other adjustments

671

(3,256)

Customer insolvency costs

1,522

Impairment charges

88,840

Acquisition-related depreciation and amortization

1,656

3,337

Other charges (credits)

530

(519)

1,695

347

Non-GAAP operating income

$        57,885

$        54,190

$       154,296

$       173,247

Non-GAAP operating margin (%)

11.7 %

11.7 %

10.9 %

12.4 %

 

EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin

Three Months Ended
September 30,

Nine Months Ended
September 30,

and Non-GAAP Net Income Reconciliations

2025

2024

2025

2024

Net income (loss) attributable to Quaker Chemical Corporation

$        30,469

$        32,346

$        (23,189)

$       102,458

Depreciation and amortization (a)

24,436

21,423

69,187

63,907

Interest expense

10,941

10,347

33,265

31,925

Taxes on income before equity in net income of associated companies (b)

 

9,266

 

12,167

 

22,280

 

40,453

EBITDA

75,112

76,283

101,543

238,743

Equity income in a captive insurance company

(1,691)

(285)

(4,437)

(1,266)

Acquisition-related step-up inventory amortization

6,022

Restructuring and related charges, net

7,745

2,610

31,128

4,787

Acquisition-related expenses

642

381

4,775

898

Loss (gain) on inventory and other adjustments

671

(3,256)

Pension and postretirement benefit costs, non-service
components

469

469

1,351

1,398

Customer insolvency costs

1,522

Impairment charges

88,840

Product liability claim costs, net

896

Business interruption insurance proceeds

(1,000)

(1,000)

Currency conversion impacts of hyper-inflationary economies

886

624

2,073

333

Loss on acquisition-related hedges

1,351

Gain on sale of assets

(2,534)

Multiemployer plan withdrawal charge

923

923

Brazilian non-income tax credits

(1,762)

(1,762)

Other charges (credits)

(144)

(520)

1,360

(176)

Adjusted EBITDA

$        82,851

$        78,562

$       227,377

$       246,135

Adjusted EBITDA margin (%)

16.8 %

17.0 %

16.0 %

17.6 %






Adjusted EBITDA

$        82,851

$        78,562

$         227,377

$         246,135

Less: Depreciation and amortization (a)

24,436

21,423

69,187

63,907

Less: Interest expense

10,941

10,347

33,265

31,925

Less: Taxes on income before equity in net income of associated companies - adjusted (b)

 

12,860

 

12,811

 

33,964

 

40,417

Plus: Acquisition-related depreciation and amortization

1,656

3,337

Non-GAAP net income

$        36,270

$        33,981

$         94,298

$         109,886

 


Three Months Ended
September 30,

Nine Months Ended
September 30,

Non-GAAP Earnings per Diluted Share Reconciliations

2025

2024

2025

2024

GAAP earnings (loss) per diluted share attributable to Quaker

Chemical Corporation common shareholders

$                1.75

$                1.81

 

$               (1.32)

 

$                 5.70

Equity income in a captive insurance company

(0.10)

(0.02)

(0.25)

(0.07)

Acquisition-related step-up inventory amortization

0.25

Restructuring and related charges, net

0.30

0.11

1.31

0.20

Acquisition-related expenses

0.02

0.02

0.21

0.04

Loss (gain) on inventory and other adjustments

0.02

(0.14)

Pension and postretirement benefit costs, non-service
components

0.02

0.02

0.06

0.06

Customer insolvency costs

0.06

Impairment charges

4.91

Product liability claim costs, net

0.04

Business interruption insurance proceeds

(0.04)

(0.04)

Currency conversion impacts of hyper-inflationary economies

0.05

0.04

0.12

0.02

Loss on acquisition-related hedges

0.06

Gain on sale of assets

(0.11)

Multiemployer plan withdrawal charge

0.04

0.04

Brazilian non-income tax credits

(0.08)

(0.08)

Other charges (credits)

0.02

(0.03)

0.07

(0.01)

Discrete tax items

(0.02)

(0.02)

0.11

0.11

Acquisition-related depreciation and amortization

0.06

0.13

Non-GAAP earnings per diluted share

$                2.08

$                1.89

$                 5.37

$                 6.11



a.

Depreciation and amortization for the three and nine months ended September 30, 2025 and 2024 each includes approximately $0.2 million and $0.7 million, respectively, of amortization expense recorded within equity in net income of associated companies in the Company's Condensed Consolidated Statements of Operations. This is attributable to the amortization of the fair value purchase accounting step-up in connection with the acquisition of the Company's 50% equity interest in Korea Houghton Corporation.



b.

Taxes on income before equity in net income of associated companies – adjusted includes the Company's tax expense adjusted for the impact of any current and deferred income tax expense (benefit), as applicable, of the reconciling items presented in the reconciliation of Net income attributable to Quaker Chemical Corporation to adjusted EBITDA, above, determined utilizing the applicable rates in the taxing jurisdictions in which these adjustments occurred, subject to deductibility. This caption also includes the impact of specific tax charges and benefits for the three and nine months ended September 30, 2025 and 2024.

Segment Measures and Reconciliations

Segment operating earnings for each of the Company's reportable segments are comprised of the segment's net sales less directly related product costs and other operating expenses. Operating expenses not directly attributable to the net sales of each respective segment, such as certain corporate and administrative costs and restructuring charges, are not included in segment operating earnings. Other items not specifically identified with the Company's reportable segments include Interest expense and Other (expense) income, net.

The following table presents information about the performance of the Company's reportable segments (dollars in thousands):


Three Months Ended
September 30,

Nine Months Ended
September 30,


2025

2024

2025

2024

Net Sales





Americas

$          222,787

$          220,275

$          657,560

$          673,546

EMEA

143,900

134,135

413,101

410,558

Asia/Pacific

127,155

107,864

349,495

311,496

Total net sales

$          493,842

$          462,274

$      1,420,156

$      1,395,600

Segment operating earnings





Americas

$            58,913

$            62,121

$          176,351

$          193,027

EMEA

26,479

24,644

74,867

80,867

Asia/Pacific

35,569

30,656

90,214

92,033

Total segment operating earnings

120,961

117,421

341,432

365,927

Restructuring and related charges, net

(7,745)

(2,610)

(31,128)

(4,787)

Impairment charges

(88,840)

Non-operating and administrative expenses

(49,560)

(47,778)

(151,137)

(149,538)

Depreciation of corporate assets and amortization

(17,015)

(15,315)

(48,572)

(45,909)

Operating income

46,641

51,718

21,755

165,693

Other (expense) income, net

(270)

783

(1,632)

2,285

Interest expense

(10,941)

(10,347)

(33,265)

(31,925)

Income (loss) before taxes and equity in net income of associated companies

 

$            35,430

 

$            42,154

 

$          (13,142)

 

$          136,053

Forward-Looking Statements

This press release contains "forward-looking statements" that fall under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and the Securities Act of 1933, as amended. These statements can be identified by the fact that they do not relate strictly to historical or current facts. We have based these forward-looking statements on assumptions, projections and expectations about future events that we believe are reasonable based on currently available information, including statements regarding the potential effects of economic downturns; tariffs, including the uncertainty surrounding changes in tariffs; inflation and global supply chain constraints on the Company's business, results of operations, and financial condition; our expectation that we will maintain sufficient liquidity and remain in compliance with the terms of the Company's credit facility; expectations about future demand and raw material costs; and statements regarding the impact of increased raw material costs and pricing initiatives. These forward-looking statements include statements with respect to our beliefs, plans, objectives, goals, expectations, anticipations, intentions, financial condition, results of operations, future performance, and business, which may differ materially from our actual results, including but not limited to the potential benefits or uncertainties of acquisitions and divestitures, the impacts on our business as a result of global supply chain constraints, and our current and future results and plans and statements that include the words "may," "could," "should," "would," "believe," "expect," "anticipate," "estimate," "intend," "outlook, "target", "possible", "potential", "plan" or similar expressions. Such statements include information relating to current and future business activities, operational matters, capital spending, and financing sources. A major risk is that demand for the Company's products and services is largely derived from the demand for our customers' products, which subjects the Company to uncertainties related to downturns in a customer's business and unanticipated customer production slowdowns and shutdowns. Other major risks and uncertainties include, but are not limited to inflationary pressures, including increases in raw material costs; supply chain constraints and the impacts of economic downturns; customer financial instability; high interest rates and their impact on our and our customers' business operations; the impacts from acts of war, terrorism and military conflicts, including those in Ukraine and the Middle East as well as economic, political and governmental actions taken by various governments and governmental organizations in response; economic and political disruptions particularly in light of numerous elections globally and the possibility of regime changes; the possibility of economic recession; legislative and regulatory developments including changes to existing laws and regulations, or the way they are interpreted, applied or enforced; tariffs, retaliatory tariffs, "trade wars" and trade restrictions, and the economic and other sanctions imposed by other nations on Russia and Belarus and/or other government organizations; suspensions of activities in Russia by many multinational companies; foreign currency fluctuations; significant changes in applicable tax rates and regulations and the potential impacts therefrom, including those arising from H.R.1, commonly known as the "One Big Beautiful Bill Act"; future terrorist attacks and other acts of violence; the impacts of consolidation in our industry, including loss or consolidation of a major customer; the effects of climate change, fires or other natural disasters; the potential occurrence of cyber-security breaches, cyber-security attacks and other technology outages and security incidents; and U.S. political conditions and legislative and regulatory activity (or inactivity), including adoption of (or failure to adopt) new laws, regulations and executive orders, changes in existing laws, regulations and executive orders or the way they are interpreted or applied, and adoption of laws, regulations or executive orders that conflict among jurisdictions in which we operate. Furthermore, the Company is subject to the same business cycles as those experienced by our customers in the steel, automotive, aerospace, industrial equipment, aluminum and durable goods industries. Our forward-looking statements are subject to risks, uncertainties and assumptions about the Company and its operations that are subject to change based on various important factors, some of which are beyond our control. These risks, uncertainties, and possible inaccurate assumptions relevant to our business could cause our actual results to differ materially from expected and historical results. All forward-looking statements included in this press release, including expectations about business conditions during 2025 and future periods, are based upon information available to the Company as of the date of this press release, which may change. Therefore, we caution you not to place undue reliance on our forward-looking statements. For more information regarding these risks and uncertainties as well as certain additional risks that we face, refer to the Risk Factors section, which appears in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2024, and in subsequent reports filed from time to time with the Securities and Exchange Commission. We do not intend to, and we disclaim any duty or obligation to, update or revise any forward-looking statements to reflect new information or future events or for any other reason. This discussion is provided as permitted by the Private Securities Litigation Reform Act of 1995.

Conference Call

As previously announced, the Company's investor conference call to discuss its third quarter of 2025 performance is scheduled for Friday, October 31, 2025 at 8:30 a.m. ET. A live webcast of the conference call, together with supplemental information, can be accessed through the Company's Investor Relations website at investors.quakerhoughton.com. You can also access the conference call by dialing 877-269-7756.

About Quaker Houghton

Quaker Houghton is the global leader in industrial process fluids. With a presence around the world, including operations in over 25 countries, our customers include thousands of the world's most advanced and specialized steel, aluminum, automotive, aerospace, offshore, container, mining, and metalworking companies. Our high-performing, innovative and sustainable solutions are backed by best-in-class technology, deep process knowledge and customized services. With approximately 4,400 employees, including chemists, engineers and industry experts, we partner with our customers to improve their operations so they can run even more efficiently, even more effectively, whatever comes next. Quaker Houghton is headquartered in Conshohocken, Pennsylvania, located near Philadelphia in the United States. Visit quakerhoughton.com to learn more.

Quaker Chemical Corporation
Condensed Consolidated Statements of Operations
(Unaudited; Dollars in thousands, except per share data)





Three Months Ended
September 30,

Nine Months Ended
September 30,


2025

2024

2025

2024

Net sales

$          493,842

$          462,274

$      1,420,156

$      1,395,600

Cost of goods sold

312,977

289,725

906,308

865,770

Gross profit

180,865

172,549

513,848

529,830

Selling, general and administrative expenses

126,479

118,221

372,125

359,350

Impairment charges

88,840

Restructuring and related charges, net

7,745

2,610

31,128

4,787

Operating income

46,641

51,718

21,755

165,693

Other (expense) income, net

(270)

783

(1,632)

2,285

Interest expense

(10,941)

(10,347)

(33,265)

(31,925)

Income (loss) before taxes and equity in net income of associated companies

 

35,430

 

42,154

 

(13,142)

 

136,053

Taxes on income before equity in net income of associated companies

 

9,266

 

12,167

 

22,280

 

40,453

Income (loss) before equity in net income of associated companies

 

26,164

 

29,987

 

(35,422)

 

95,600

Equity in net income of associated companies

4,322

2,385

12,262

6,940

Net income (loss)

30,486

32,372

(23,160)

102,540

Less: Net income attributable to noncontrolling interest

17

26

29

82

Net income (loss) attributable to Quaker Chemical Corporation

$            30,469

$            32,346

$          (23,189)

$          102,458

Per share data:





Net income (loss) attributable to Quaker Chemical Corporation
common shareholders – basic

 

$                1.75

 

$                1.81

 

$               (1.32)

 

$                5.71

Net income (loss) attributable to Quaker Chemical Corporation
common shareholders – diluted

 

$                1.75

 

$                1.81

 

$               (1.32)

 

$                5.70

Basic weighted average common shares outstanding

17,363,947

17,837,858

17,524,377

17,889,168

Diluted weighted average common shares outstanding

17,421,090

17,864,335

17,545,666

17,909,967

 

Quaker Chemical Corporation

Condensed Consolidated Balance Sheets

(Unaudited; Dollars in thousands, except par value)


September 30,

2025

December 31,

2024

ASSETS



Current assets



Cash and cash equivalents

$           172,038

$          188,880

Accounts receivable, net

436,216

400,126

Inventories

268,608

227,472

Prepaid expenses and other current assets

69,123

59,939

Total current assets

945,985

876,417




Property, plant and equipment, net

295,784

229,532

Right-of-use lease assets

38,454

34,120

Goodwill

501,767

518,894

Other intangible assets, net

890,645

827,098

Investments in associated companies

106,783

98,012

Deferred tax assets

10,050

9,216

Other non-current assets

27,329

17,360

Total assets

$       2,816,797

$      2,610,649




LIABILITIES AND EQUITY



Current liabilities



Short-term borrowings and current portion of long-term debt

$             35,949

$            37,554

Accounts payable

205,541

198,137

Dividends payable

8,825

8,572

Accrued compensation

42,095

50,212

Accrued restructuring

4,800

2,297

Accrued pension and postretirement benefits

2,259

2,328

Other accrued liabilities

83,930

80,668

Total current liabilities

383,399

379,768




Long-term debt

838,522

669,614

Long-term lease liabilities

22,637

20,028

Deferred tax liabilities

150,726

138,828

Non-current accrued pension and postretirement benefits

23,769

23,783

Other non-current liabilities

30,861

24,445

Total liabilities

1,449,914

1,256,466


Equity



Common stock $1 par value; authorized 30,000,000 shares; issued and outstanding
   September 30, 2025 – 17,367,942 shares; December 31, 2024 – 17,673,607 shares

 

17,368

 

17,674

Capital in excess of par value

876,911

903,781

Retained earnings

584,706

633,731

Accumulated other comprehensive loss

(115,333)

(201,619)

Total Quaker shareholders' equity

1,363,652

1,353,567

Noncontrolling interest

3,231

616

Total equity

1,366,883

1,354,183

Total liabilities and equity

$       2,816,797

$      2,610,649

 

Quaker Chemical Corporation
Condensed Consolidated Statements of Cash Flows
(Unaudited; Dollars in thousands)



Nine Months Ended
September 30,


2025

2024

Cash flows from operating activities



Net (loss) income

$          (23,160)

$          102,540

Adjustments to reconcile net (loss) income to net cash provided by operating activities:



Depreciation and amortization

68,471

63,159

Equity in undistributed earnings of associated companies, net of dividends

(4,366)

1,045

Deferred income taxes

(16,503)

(7,934)

Share-based compensation

10,419

12,413

Impairment charges

88,840

Restructuring and related charges, net

31,128

4,787

Inventory step-up amortization

6,022

Gain on disposal of property, plant, equipment and other assets

(2,051)

Other adjustments

(5,082)

(4,325)

Increase (decrease) in cash from changes in current assets and current liabilities, net of acquisitions:



Accounts receivable

4,585

20,625

Inventories

(16,473)

(10,875)

Prepaid expenses and other current assets

(4,258)

(7,912)

Accrued restructuring

(21,671)

(6,397)

Accounts payable and accrued liabilities

(25,992)

(25,612)

 Net cash provided by operating activities

89,909

141,514

Cash flows from investing activities



Investments in property, plant and equipment

(33,630)

(19,337)

Payments related to acquisitions, net of cash acquired

(164,209)

(39,302)

Proceeds from disposition of assets

2,992

2,798

Other investing activities

1,828

 Net cash used in investing activities

(193,019)

(55,841)

Cash flows from financing activities



Payments of long-term debt

(25,967)

(48,600)

Borrowings on revolving credit facilities, net

168,938

30,500

Payments on other debt, net

(525)

(842)

Dividends paid

(25,583)

(24,523)

Shares purchased under share repurchase programs

(36,496)

(22,906)

Other stock related activity

(1,099)

(631)

 Net cash provided by (used in) financing activities

79,268

(67,002)

 Effect of foreign exchange rate changes on cash

7,000

(1,124)

Net (decrease) increase in cash and cash equivalents

(16,842)

17,547

Cash and cash equivalents at the beginning of the period

188,880

194,527

Cash and cash equivalents at the end of the period

$          172,038

$          212,074

 

Quaker Houghton (PRNewsfoto/Quaker Houghton)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/quaker-houghton-announces-third-quarter-2025-results-302600230.html

SOURCE Quaker Chemical Corporation

In eigener Sache

Übrigens: Quaker Chemical und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Quaker Chemical

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Quaker Chemical

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Quaker Chemical CorpShs

Wer­bung

Analysen zu Quaker Chemical CorpShs

DatumRatingAnalyst
27.10.2016Quaker Chemical HoldWunderlich
13.01.2016Quaker Chemical AccumulateSeaport Global Securities
04.06.2015Quaker Chemical NeutralGlobal Hunter Securities
30.04.2015Quaker Chemical HoldWunderlich
14.10.2014Quaker Chemical HoldWunderlich
DatumRatingAnalyst
13.01.2016Quaker Chemical AccumulateSeaport Global Securities
DatumRatingAnalyst
27.10.2016Quaker Chemical HoldWunderlich
04.06.2015Quaker Chemical NeutralGlobal Hunter Securities
30.04.2015Quaker Chemical HoldWunderlich
14.10.2014Quaker Chemical HoldWunderlich
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Quaker Chemical CorpShs nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen